Mark Tompkins (Montrose Capital Partners)

Venture capital firm

Value Add VC tracks 1 company Mark Tompkins (Montrose Capital Partners) has invested in.

Mark Tompkins (Montrose Capital Partners) key facts

FactValueSource
TypeVenture capital firmValue Add VC classification
Portfolio companies tracked1Portfolio list on this page

Is something wrong on this page?

Mark Tompkins (Montrose Capital Partners) profile

written 2026-11-07

Mark Tompkins founded Montrose Capital Partners in 2001 and backs startups like Matternet and Serve Robotics by taking them public through shell mergers.

Who Mark Tompkins is

Mark Tompkins is an individual investor, not a venture fund. SEC filings describe him as a founder of Montrose Capital Partners Limited who has served as its president since the firm's inception in 2001, and as an officer and principal owner of Montrose Capital.[1]

Montrose Capital is described in the same filings as a privately held company that focuses on "identifying public markets venture capital investment opportunities in high growth early stage companies." It is sector agnostic and has invested, through its principal owners, in biotechnology, specialty pharmaceuticals, medical devices, robotics and technology. A 2017 Schedule 13D gave Montrose Capital's address as St. James's Place in London and named Tompkins its Managing Director.[1],[2]

How Montrose invests

SEC filings show a repeated pattern. Tompkins and associates such as Ian Jacobs register a shell company on Form 10, sit on its board and lend it money for expenses. The shell later merges with a private company, which becomes a public reporting company in the same step; in the Matternet deal, the merger came with a private placement at closing.[1],[3]

Orielle Acquisition Corp., registered in 2025, is a current example. Its Form 10 names Ian Jacobs, an associate of Montrose Capital since 2008, as sole officer and Tompkins as director, and says the company issued Tompkins a promissory note to repay whatever he advances for expenses before a business combination. It says Montrose Capital may help find and diligence a merger target.[1]

Track record

Orielle's filing lists the shells Tompkins has served as a director of and the public companies they became: Max-1 Acquisition Corporation (now Exicure), Lola One Acquisition Corporation (now Amesite), Peninsula Acquisition Corporation (now Transphorm), Olivia Ventures (now Compass Therapeutics), Malo Holdings Corporation (now Augmedix) and Parasol Investments Corporation (now SmartKem).[1]

The same list continues with Parc Investments (now Aeluma), Laffin Acquisition Corp. (now Guerrilla RF), Patricia Acquisition Corp. (now Serve Robotics, which trades on Nasdaq as SERV), and Venetian-1 Acquisition Corp. (now Lomond Therapeutics Holdings). He was also a director of Odyssey Semiconductor Technologies in 2019 and of Perfect Moment Ltd. in early 2021. He has been a director of Aspen-1 Acquisition Inc. and Surfside Acquisition Inc. since December 2021.[1]

The listings describe directorships and the companies' later names. They do not report what Tompkins or Montrose paid or earned on any of these deals, and Value Add VC does not estimate it.[1]

Matternet

Tompkins's most recent tracked deal is Matternet, the drone delivery company. In May 2026 Matternet went public through a reverse merger with Los Altos Ventures Corp., a shell where Tompkins had been a director and stockholder. Matternet's press release said it raised approximately $33 million in an oversubscribed private placement, led by new investors including Ed Eisler of EE Holdings and Mark Tompkins of Montrose Capital Partners.[4],[3]

Matternet's 8-K puts the private placement at 9,212,773 shares sold at $3.00 per share, for gross proceeds of $27.6 million before about $6.9 million of placement agent fees and expenses. Before the merger, 7,300,000 of the shell's 10,000,000 shares held by pre-merger stockholders were forfeited and cancelled, leaving them 2,700,000 shares.[3]

At closing Matternet repaid $55,000 to Tompkins in full under a June 2025 promissory note covering shell expenses. Its beneficial ownership table lists Tompkins as a 5% stockholder with 4,729,166 shares, or 9.9%, second only to CEO Andreas Raptopoulos.[3]

What founders should know

A Montrose shell is a route to becoming a public reporting company without an IPO; at Matternet it was paired with a private placement that Tompkins helped lead. The filings show the trade-offs founders negotiate: the shell's pre-merger holders keep a stake after a share forfeiture, the shell's expenses are repaid at closing, and the new company takes on registration rights obligations and SEC reporting from day one.[3],[1]

Tompkins usually leaves the board at or after the merger. In the Serve Robotics case his directorship ran from November 2020 to July 2023, according to Orielle's filing.[1]

Frequently asked questions

Is Mark Tompkins a venture capitalist? He invests in early-stage companies, but through public-market shells and private placements rather than a traditional venture fund. Montrose Capital calls its focus public markets venture capital opportunities.[1]

What is Montrose Capital Partners? A privately held company founded in 2001, with Tompkins as president, that invests through its principal owners across sectors.[1]

What companies has Mark Tompkins backed? SEC filings tie him to Matternet, Serve Robotics, Exicure, Amesite, Transphorm, Compass Therapeutics, Augmedix, SmartKem, Aeluma, Guerrilla RF and Lomond Therapeutics, among others.[1],[3]

Portfolio

1 total

Co-Investors

1

Similar Firms

overlapping sector, stage or region

Latest Pulse

  1. Matternet Becomes First Pure-Play Drone Delivery Company to Go PublicMatternet, the FAA type-certified drone delivery platform, completed a reverse merger to go public and raised $33 million in a private placement alongside the transaction, closing May 22 and making it the first publicly reporting company focused exclusively on drone delivery. CEO Andreas Raptopoulos framed 2026 as the inflection point for U.S. drone delivery as the company expands across healthcare, retail and restaurant delivery.โ†’

Mark Tompkins (Montrose Capital Partners) FAQ

What companies has Mark Tompkins (Montrose Capital Partners) backed?

Companies Value Add VC tracks as Mark Tompkins (Montrose Capital Partners) investments include Matternet.

Who does Mark Tompkins (Montrose Capital Partners) co-invest with most?

In the rounds Value Add tracks, Mark Tompkins (Montrose Capital Partners) most often invests alongside Winklevoss Capital (1 shared deal).